ALS

Approximately 4,000 Canadians are living with amyotrophic lateral sclerosis (ALS) – a devastating neurodegenerative disease affecting nerve cells in the brain and spinal cord, causing loss of muscle control. Some patients may live with ALS for decades, while others decline rapidly. Brain Canada funds cutting-edge research that could support better diagnosis and treatment to improve the lives of people living with ALS.

A smiling female doctor standing with a group of three doctor in a hospital hallway
Dr. Angela Genge, Brain Canada-funded researcher and Director of the ALS Centre of Excellence for Research and Patient Care, with her team at The Neuro (Montreal Neurological Institute-Hospital) in 2021.

Our Projects

Brain Canada’s rigorous scientific review process gives donors and partners a trusted mechanism to ensure projects are chosen based on merit, innovation, and potential for impact.

Search the directory

$30,939,818 invested

96 grants awarded

Impact News

How we are advancing brain health

Our Partners

View all our partners

Making a significant difference in the lives of people in Canada doesn’t happen in a vacuum. It takes a network of visionary partners committed to investing in change. As a national convenor and facilitator, Brain Canada works with partners from coast to coast to drive innovative brain research. Some of our partners in supporting ALS research include:

ALS Society of Canada
Alnylam Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.

How you can help

Brain Canada funds the very best Canadian neuroscience, fostering collaborative research and accelerating the pace of discovery, in order to improve the health and quality of life of Canadians who suffer from brain disorders.

Donate
Learn more